| Authors: |
Smith DJ; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, United States.; COVID-19 Response International Task Force, Centers for Disease Control and Prevention, Atlanta, GA, United States., Bi H; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China., Hamman J; Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa., Ma X; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States., Mitchell C; Health and Environmental Sciences Institute, Washington, DC, United States., Nyirenda K; Department of Pharmacy, Kamuzu University of Health Sciences, Blantyre, Malawi., Monera-Penduka T; Research Unit for Safety of Herbs and Drugs, University of Zimbabwe, Harare, Zimbabwe., Oketch-Rabah H; United States Pharmacopeia, Rockville, MD, United States., Paine MF; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States., Pettit S; Health and Environmental Sciences Institute, Washington, DC, United States., Pheiffer W; DSI/NWU Preclinical Drug Development Platform, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa., Van Breemen RB; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR, United States., Embry M; Health and Environmental Sciences Institute, Washington, DC, United States. |
